GLP-1 and Constipation:
Why It Happens and What Actually Helps

If nausea gets most of the attention when people talk about GLP-1 side effects, constipation is its quieter, more persistent counterpart. Patients often mention it almost apologetically — as if they're not sure it's worth bringing up. It is. Constipation on GLP-1 therapy is common, it can be uncomfortable enough to affect adherence, and there are very specific, evidence-based things you can do about it.

The good news: constipation is one of the more fixable GLP-1 side effects — if you know the right order of interventions and understand the one key tension that catches a lot of people off guard (more on that below).

How common is GLP-1 constipation?

More common than most patients expect — and the rates are higher with tirzepatide than semaglutide:

Like nausea, constipation is dose-related — it tends to be most common and most pronounced at the higher doses, and most likely to appear or worsen during dose escalation. It typically improves once you've been stable on a dose for several weeks. But unlike nausea — which often fades on its own as the body adapts — constipation can persist throughout treatment if it isn't actively managed with diet and lifestyle changes.

Why GLP-1 medications cause constipation

There isn't a single cause — constipation on these medications results from several overlapping mechanisms that all slow down your digestive tract in different ways.

These mechanisms compound each other. Slower transit + less stool bulk + less fluid = a recipe for constipation that won't resolve on its own without deliberate management.

The nausea-fiber trade-off: what no one tells you

Here's the clinical tension that catches patients off guard: the two most common GLP-1 side effects — nausea and constipation — require partially opposite dietary approaches. Understanding this trade-off will help you navigate both.

The key insight is that these aren't fully contradictory — they're sequential. In the early weeks of treatment or after a dose increase, when nausea is most active, prioritizing low-fiber easily digested foods makes sense. As nausea settles, gradually reintroducing fiber — starting with soluble fiber, which is gentler on a sensitive stomach than insoluble fiber — is the move.

The other key: don't dump fiber in all at once. Increase gradually — by about 5g per day per week — to avoid the bloating and gas that come from too-much-too-fast, which can be easily mistaken for worsening GI side effects from the medication.

Foods that help — and foods that make it worse

The goal is to choose foods that support motility and stool consistency without overwhelming a stomach that may still be sensitive. Soluble fiber is your priority here — it softens stool without the bulk and gas of insoluble fiber.

Hydration: the most overlooked fix

GLP-1 medications suppress thirst cues along with appetite. Many patients on these medications are chronically under-hydrated without realizing it — and inadequate hydration is one of the single most consistent contributors to constipation, both on and off GLP-1 therapy.

Aim for a minimum of 2 liters (~64 oz, or about eight 8-oz glasses) of fluid per day, and more if you are active, in a warm climate, or increasing your fiber intake. Signs you may be under-hydrated: urine that is dark yellow, infrequent urination, persistent headaches, or feeling sluggish even when well-rested.

• Warm liquids in the morning — a warm cup of water (8–12 oz / 240–360ml), coffee, or herbal tea on an empty stomach can stimulate the gastrocolic reflex, which triggers bowel contractions. This is one of the most underutilized and lowest-effort constipation strategies.
• Hydrate with fiber — psyllium husk, chia seeds, and other soluble fiber supplements must be taken with a full glass of water (at least 8 oz / 240ml) and followed by consistent fluid intake throughout the day. Without this, they can form a mass that makes constipation worse.
• Distribute fluid across the day — sipping steadily throughout the day is more effective than drinking large volumes at once. A useful visual target: pale yellow urine by mid-morning.

Movement and bowel regularity

Physical activity directly stimulates gut motility — it's one of the few interventions with consistent evidence across multiple constipation types. You don't need intense exercise. Even a 15–20 minute walk after meals can meaningfully support transit time.

This matters particularly for GLP-1 patients because reduced appetite often reduces energy, and some patients become less active during the initial phase of treatment. If you're also managing nausea, light walking after meals is actually compatible with nausea management (unlike vigorous exercise immediately after eating).

Step-by-step management: where to start

Constipation management works best as a stepwise approach — starting with the simplest interventions before adding supplements or medications. Most patients resolve their constipation at step 1 or 2.

OTC remedies: what works, what to avoid, and what to never use long-term

Distinguishing constipation from gastroparesis

This distinction matters clinically and is worth understanding. Both constipation and gastroparesis (significant delayed gastric emptying) can occur on GLP-1 therapy, but they present differently and are managed differently.

Typical GLP-1 constipation — what most patients experience — presents as infrequent, hard stools, straining, and bloating in the lower abdomen. It's primarily a colonic motility issue.

Gastroparesis is a more significant upper GI motility disorder. Symptoms to watch for that suggest something beyond routine constipation include: early satiety (feeling full after just a few bites), persistent nausea and vomiting of undigested food, upper abdominal fullness and pain, and nausea that doesn't improve after weeks at a stable dose. Research using wireless motility capsule testing has found that GLP-1 therapy can affect colonic transit time independently of gastric emptying — meaning some patients may experience significant colonic slowing without classic gastroparesis symptoms.

If you have any of these upper GI symptoms alongside your constipation, let your provider know. These can signal that your GI motility is more significantly affected and may warrant a different management approach.

When to call your provider

Most constipation on GLP-1 therapy is manageable at home. These situations warrant a call to your provider:

The bottom line

Constipation on GLP-1 therapy is common, dose-related, and predictable — but it doesn't have to derail your treatment. The vast majority of cases respond very well to three things: more water, gradual soluble fiber, and daily movement. Most patients never need laxatives at all if they build these habits proactively at the start of treatment.

One clinical point worth carrying forward: constipation that isn't managed is a reason to pause your dose escalation, not push through it. Increasing the dose before your GI system has adjusted will predictably make constipation worse. Your provider should be confirming at each visit that you're tolerating the current dose well before moving you up. If they haven't asked about constipation, bring it up — it matters.

And if you're managing both nausea and constipation simultaneously — common in the early weeks — start with hydration, introduce soluble fiber slowly, and be patient. Both typically improve as your dose stabilizes. You don't have to choose between them. You just have to be strategic about the order.